Massachusetts-based biotech firm KnipBio said Wednesday it saw positive results for a series of five separate experimental feed trials conducted at multiple locations recently.

In the trials, the company fed post-larvae Pacific white shrimp a diet that included the KnipBio Meal (KBM) single-cell protein.

The shrimp had "significantly higher survival rates when compared to shrimp fed a standard commercial fishmeal-based diet ... under normal conditions as well as in populations undergoing disease stress," it said.

Trials were conducted at Roger Williams University, other US universities and a scientific research facility in Asia.